Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates

scientific article

Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.MT.6300185
P698PubMed publication ID17505477
P5875ResearchGate publication ID6327857

P50authorBashir JarrayaQ37838455
Jocelyne BlochQ38548794
Emmanuel BrouilletQ42839922
Nicole DéglonQ47503901
S PalfiQ67207767
Philippe HantrayeQ67207772
P2093author name stringPatrick Aebischer
Xiao-Jiang Li
Caroline Jan
Masahiro Shin
Françoise Condé
P2860cites workA novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.Q27860836
Transgenic monkeys produced by retroviral gene transfer into mature oocytesQ28201614
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutationQ28246858
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyQ28270776
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in miceQ28505664
Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicityQ28513938
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vectorQ29547503
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral VectorsQ29547596
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brainQ29617982
Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryosQ30476162
Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.Q30580639
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's diseaseQ33703899
Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primatesQ34103541
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidQ34384772
Mouse models of Huntington's diseaseQ34502714
Huntingtin-protein interactions and the pathogenesis of Huntington's diseaseQ35704403
A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity dataQ36459326
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineQ37343442
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseQ37953193
Presymptomatic and early detection in Huntington's diseaseQ40217729
Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.Q40644113
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's diseaseQ40846012
Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus.Q40866683
Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.Q40876522
Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's diseaseQ40904090
A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboonQ41197259
Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of choreaQ41400116
Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.Q42279258
MRI-stereotactical approach for neural grafting in basal ganglia disorders.Q42453128
Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical studyQ42465693
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeysQ42488566
Functional integration of striatal allografts in a primate model of Huntington's disease.Q42541733
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural studyQ42632778
Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatumQ43781780
Lentiviral gene transfer to the nonhuman primate brainQ44028201
Transgenic rat model of Huntington's diseaseQ44350467
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models.Q45288480
Tourettism associated with Huntington's diseaseQ45288922
Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's diseaseQ45291813
Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington diseaseQ45296323
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.Q45297497
Tourettism as clinical presentation of Huntington's disease with onset in childhoodQ45300997
Organization of corticostriatal motor inputs in monkey putamenQ48475327
Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesiaQ48661195
Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkeyQ52206147
The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technicsQ72640463
cFos immunoreactivity is enhanced with biotin amplificationQ72864660
P433issue8
P921main subjectputamenQ550934
P304page(s)1444-1451
P577publication date2007-05-01
P1433published inMolecular TherapyQ15762400
P1476titleExpression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates
P478volume15